These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7254109)

  • 1. In-vitro activity of erythromycin against anaerobic microorganisms.
    Harvey KJ; Miles H; Hurse A; Carson M
    Med J Aust; 1981 May; 1(9):474-5. PubMed ID: 7254109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of carbon dioxide on in vitro susceptibility of anaerobic bacteria to erythromycin.
    Goldstein EJ; Sutter VL; Kwok YY; Lewis RP; Finegold SM
    Antimicrob Agents Chemother; 1981 Dec; 20(6):705-8. PubMed ID: 6798927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic action of erythromycin and cefamandole against Bacteroides fragilis subsp. fragilis.
    Griffith RS; Brier GL; Wolny JD
    Antimicrob Agents Chemother; 1977 May; 11(5):813-6. PubMed ID: 879736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in-vitro activity of azithromycin and erythromycin against Gram-positive cocci, Haemophilus influenzae and anaerobes.
    Maskell JP; Sefton AM; Williams JD
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():19-24. PubMed ID: 2154433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro comparison of roxithromycin and erythromycin against 900 anaerobic bacterial strains.
    Dubreuil L
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():13-9. PubMed ID: 3429381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosamicin: in vitro activity against anaerobes and comparison with erythromycin.
    Sutter VL; Finegold SM
    Antimicrob Agents Chemother; 1976 Feb; 9(2):350-1. PubMed ID: 1267432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
    Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
    Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carbon dioxide and pH on susceptibility of Bacteroides fragilis group to erythromycin.
    Hansen SL; Swomley P; Drusano G
    Antimicrob Agents Chemother; 1981 Feb; 19(2):335-6. PubMed ID: 6812492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity and clinical efficacy of clindamycin in the treatment of infections due to anaerobic bacteria.
    Levison ME; Santoro J; Bran JL; Ries K; Rubin W
    J Infect Dis; 1977 Mar; 135 Suppl():S49-53. PubMed ID: 850091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disc diffusion method to screen for high-level resistance to clindamycin and erythromycin in the Bacteroides fragilis group.
    Callihan DR; Nolte FS
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):131-7. PubMed ID: 3979019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of pristinamycin and its components against gram-negative anaerobic bacilli and Gardnerella vaginalis.
    Weber P; Dubois S; Boussougant Y
    J Antimicrob Chemother; 1989 Jun; 23(6):825-30. PubMed ID: 2503487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activities of four macrolides: josamycin, erythromycin, spiramycin and roxithromycin, against 424 anaerobic bacteria.
    Derriennic M; Dubreuil L; Reynaud AE; Courtieu AL
    Chemioterapia; 1987 Jun; 6(2 Suppl):159-60. PubMed ID: 3509376
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasmid-mediated, transferable resistance to clindamycin and erythromycin in Bacteroides fragilis.
    Tally FP; Snydman DR; Gorbach SL; Malamy MH
    J Infect Dis; 1979 Jan; 139(1):83-8. PubMed ID: 438530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in-vitro activity of erythromycin, vancomycin and pristinamycin.
    Maskell JP; Sefton AM; Yong J; Chi SJ; Williams JD
    Infection; 1988; 16(6):365-70. PubMed ID: 3146552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotics of choice against Bacteroides fragilis.
    Bittner J; Voinescu V; Munteanu V; Antohi M; Ardeleanu J
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):213-8. PubMed ID: 7159211
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of carbon dioxide on the sensitivity of Bacteroides fragilis to certain antibiotics in vitro.
    Ingham HR; Selkon JB; Codd AA; Hale JH
    J Clin Pathol; 1970 Apr; 23(3):254-8. PubMed ID: 5310276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
    Tytgat F
    Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal activity of tinidazole. An in vitro comparison of the effects of tinidazole and metronidazole against Bacteroides fragilis and other Anaerobic bacteria.
    Jokipii AM; Jokipii L
    Chemotherapy; 1977; 23(1):25-31. PubMed ID: 318974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in-vitro activity of roxithromycin, a new macrolide antibiotic, in comparison with that of erythromycin.
    King A; Phillips I
    Drugs Exp Clin Res; 1987; 13(9):563-6. PubMed ID: 3428135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfer of multiple antibiotic resistance between subspecies of Bacteroides fragilis.
    Privitera G; Dublanchet A; Sebald M
    J Infect Dis; 1979 Jan; 139(1):97-101. PubMed ID: 108340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.